or Try an Advanced Search...

    Recombinant Proteins Stocks List

    Symbol Grade Name % Change
    MODD B Modular Medical, Inc. 1.38
    AMGN C Amgen Inc. -0.29
    ASND F Ascendis Pharma A/S 2.00
    CHRS F Coherus BioSciences, Inc. -2.95
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Biotechnology Medicine Diabetes Insulin Peptide Hormones Adalimumab Biopharmaceutical Biosimilar Blood Cells Bone Bone Disease Breakthrough Therapy Breast Cancer Cancer Care Chemotherapy Clinic Clinical Medicine Dialysis Disease Dow Jones Component

    Related ETFs - A few ETFs which own one or more of the above listed Recombinant Proteins stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 16.72
    MEDI D Harbor Health Care ETF 15.43
    HRTS D Tema Cardiovascular and Metabolic ETF 9.93
    BIS C ProShares UltraShort Nasdaq Biotechnology 9.07
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.64
    View all Recombinant Proteins ETFs...
    Compare ETFs
    Compare BBH to BIS Compare BBH to IBBQ Compare MEDI to HRTS

        Recombinant Proteins Stocks Recent News

        Date Stock Title
        Nov 1 AMGN Amgen Third Quarter 2024 Earnings: EPS Beats Expectations
        Oct 31 MODD New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
        Oct 31 AMGN Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight
        Oct 31 AMGN Q3 2024 Amgen Inc Earnings Call
        Oct 31 AMGN Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
        Oct 31 AMGN Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
        Oct 31 AMGN Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
        Oct 31 AMGN Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript
        Oct 31 AMGN Amgen Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 31 AMGN Amgen (AMGN) Q3 2024 Earnings Call Transcript
        Oct 30 AMGN Amgen updates 2024 guidance with revenue and EPS ranges including consensus
        Oct 30 AMGN Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics
        Oct 30 AMGN Amgen (AMGN) Beats Q3 Earnings Estimates
        Oct 30 CHRS Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024
        Oct 30 AMGN Amgen in charts: Prolia, XGEVA sales gain, while Enbrel continues to wind down in Q3
        Oct 30 AMGN Amgen: Q3 Earnings Snapshot
        Oct 30 AMGN Amgen Non-GAAP EPS of $5.58 beats by $0.47, revenue of $8.5B in-line
        Oct 30 AMGN Amgen posts higher profit, obesity data on track for late this year
        Oct 30 AMGN AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
        Oct 29 AMGN Amgen Q3 2024 Earnings Preview: All eyes on obesity candidate data
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Biotechnology Medicine Diabetes Insulin Peptide Hormones Adalimumab Biopharmaceutical Biosimilar Blood Cells Bone Bone Disease Breakthrough Therapy Breast Cancer Cancer Care Chemotherapy Clinic Clinical Medicine Dialysis Disease Dow Jones Component
        Recombinant Proteins

        Recombinant proteins are proteins that are produced through genetic engineering. They are created by inserting a gene from one organism into another organism, such as a bacteria or yeast, which then produces the desired protein. Recombinant proteins are used in a variety of applications, including medical treatments, research, and industrial processes.

        Browse All Tags